Article
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function
13 Jul 2023
Abstract excerpt
Lysine-specific demethylase 1 (LSD1) is a histone demethylase that promotes stemness and cell survival in cancers such as prostate cancer. Most prostate malignancies are adenocarcinomas with luminal differentiation. However, some tumors undergo cellular reprogramming to a more lethal subset termed neuroendocrine prostate cancer (NEPC) with neuronal differentiation. The frequency of NEPC is increasing since the...
Topics
Join the communities discussing this publication.